These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23423609)

  • 1. Amadori glycated proteins: role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation.
    Ansari NA; Dash D
    Aging Dis; 2013 Feb; 4(1):50-6. PubMed ID: 23423609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated lysine residues: a marker for non-enzymatic protein glycation in age-related diseases.
    Ansari NA; Moinuddin ; Ali R
    Dis Markers; 2011; 30(6):317-24. PubMed ID: 21725160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: role of protein glycation in the disease process.
    Ansari NA; Moinuddin ; Alam K; Ali A
    Hum Immunol; 2009 Jun; 70(6):417-24. PubMed ID: 19332092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of early glycation Amadori products of lysine-rich proteins in the production of autoantibodies in diabetes type 2 patients.
    Ansari NA; Moinuddin ; Mir AR; Habib S; Alam K; Ali A; Khan RH
    Cell Biochem Biophys; 2014 Nov; 70(2):857-65. PubMed ID: 24789546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.
    Neelofar K; Ahmad J
    Glycoconj J; 2017 Oct; 34(5):575-584. PubMed ID: 28812216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-enzymatic glycation of proteins: from diabetes to cancer].
    Ansari NA; Rasheed Z
    Biomed Khim; 2010; 56(2):168-78. PubMed ID: 21341505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amadori albumin in diabetic nephropathy.
    Neelofar K; Ahmad J
    Indian J Endocrinol Metab; 2015; 19(1):39-46. PubMed ID: 25593824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helical peptide models for protein glycation: proximity effects in catalysis of the Amadori rearrangement.
    Venkatraman J; Aggarwal K; Balaram P
    Chem Biol; 2001 Jul; 8(7):611-25. PubMed ID: 11451663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating the impact of glucosylation on human serum albumin: A multi-technique approach.
    Neelofar KM; Ahmad J; Arif Z; Alam K
    Int J Biol Macromol; 2016 Nov; 92():881-891. PubMed ID: 27492562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiological role of Amadori-glycated proteins in diabetic microangiopathy.
    Schalkwijk CG; Lieuw-a-Fa M; van Hinsbergh VW; Stehouwer CD
    Semin Vasc Med; 2002 May; 2(2):191-7. PubMed ID: 16222610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-enzymatic glycation of proteins: a cause for complications in diabetes.
    Nawale RB; Mourya VK; Bhise SB
    Indian J Biochem Biophys; 2006 Dec; 43(6):337-44. PubMed ID: 17285797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
    Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
    Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.
    Schalkwijk CG; Ligtvoet N; Twaalfhoven H; Jager A; Blaauwgeers HG; Schlingemann RO; Tarnow L; Parving HH; Stehouwer CD; van Hinsbergh VW
    Diabetes; 1999 Dec; 48(12):2446-53. PubMed ID: 10580435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-enzymatic glucosylation induced neo-epitopes on human serum albumin: A concentration based study.
    Neelofar K; Arif Z; Ahmad J; Alam K
    PLoS One; 2017; 12(2):e0172074. PubMed ID: 28192530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment.
    Jaleel A; Halvatsiotis P; Williamson B; Juhasz P; Martin S; Nair KS
    Diabetes Care; 2005 Mar; 28(3):645-52. PubMed ID: 15735202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy.
    Cohen MP; Ziyadeh FN
    J Am Soc Nephrol; 1996 Feb; 7(2):183-90. PubMed ID: 8785386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics.
    Schalkwijk CG; Miyata T
    Amino Acids; 2012 Apr; 42(4):1193-204. PubMed ID: 20960212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and immunological characterization of Amadori-rich human serum albumin: role in diabetes mellitus.
    Arif B; Ashraf JM; Moinuddin ; Ahmad J; Arif Z; Alam K
    Arch Biochem Biophys; 2012 Jun; 522(1):17-25. PubMed ID: 22516656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amadori-glycated phosphatidylethanolamine, a potential marker for hyperglycemia, in streptozotocin-induced diabetic rats.
    Sookwong P; Nakagawa K; Fujita I; Shoji N; Miyazawa T
    Lipids; 2011 Oct; 46(10):943-52. PubMed ID: 21732214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of acetoacetate in Amadori product formation of human serum albumin.
    Bohlooli M; Ghaffari-Moghaddam M; Khajeh M; Shahraki-Fallah G; Haghighi-Kekhaiye B; Sheibani N
    J Photochem Photobiol B; 2016 Oct; 163():345-51. PubMed ID: 27614245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.